Newsletter | June 26, 2020

06.26.20 -- Moving From Crisis To Lasting Change

 
Web-Exclusive Content
Moving From Crisis To Lasting Change
 

Richard Pops of Alkermes says our industry has an opportunity — an obligation really — to harness and improve upon the efforts made over the last few months to formalize a new operating model utilizing all of the clinical, digital, and pharmacological tools at our disposal to raise the standard of care for people well into the future.

Magazine Content
Use Of Outside Consultants In Phase 2/3 Clinical Research
 

In addition to the role that preferred provider agreements (PPAs) play in the process, companies also seek assistance from specialized outside consultants to help with their outsourcing decisions.

A Biopharma Dealmaker’s Approach To Maximizing Strategic Partnerships
 

Locust Walk examined 129 deals involving publicly traded U.S. companies over the four-year period from 2016 through 2019 in which the value of the deals was disclosed.

Insights Into The Competitive Clinical Manufacturing Market
 

There are perhaps too many options when it comes to choosing the right service provider for clinical manufacturing. Drug innovators weigh in on their selection metrics and preferences and also reveal why vendors lose bids.

June 2020 Digital Edition
 

Inside you will find more on:

  • Ugur Sahin Of BioNTech Tells His Story
  • Ask The Board Q&A
  • Financial Portfolio Management
  • From Policy To Execution Column

View the digital edition.

Contribute To Life Science Leader
Article Submission Guidelines
 

Think you have a good idea for an article that Life Science Leader readers would find valuable? Read these guidelines first before submitting your idea or your article to our editorial director.